Status:
RECRUITING
Prospective Evaluation of Single Cell Mutations in a Panel of Known Oncogenes in NSCLC Surgical Specimens
Lead Sponsor:
University of Milano Bicocca
Conditions:
NSCLC
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to evaluate the feasibility of a single cell mutation research method in a panel of known oncogenes, using the Tapestri method. Tissue samples will be obtained ...
Detailed Description
NSCLC is a particularly heterogeneous disease with different genetic alterations in oncogenes 'drivers', responsible for the development and progression of the disease. In most cases all these anomali...
Eligibility Criteria
Inclusion
- age over 18 years old.
- histological diagnosis of NSCLC technically operable following multidisciplinary discussion
- informed consent freely granted and obtained before the start of the study
Exclusion
- age under 18 years old
- unconfirmed NSCLC histological diagnosis
- medical treatment with neoadjuvant purposes
- absence of informed consent
Key Trial Info
Start Date :
April 3 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06050278
Start Date
April 3 2023
End Date
April 1 2026
Last Update
December 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione IRCCS San Gerardo dei Tintori
Monza, MB, Italy, 20900